Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
31.5M
-
Shares change
-
+6.06M
-
Total reported value, excl. options
-
$310M
-
Value change
-
+$57.2M
-
Put/Call ratio
-
0.73
-
Number of buys
-
64
-
Number of sells
-
-56
-
Price
-
$9.84
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2017
158 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2017.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.5M shares
of 79.5M outstanding shares and own 39.67% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.26M shares), VANGUARD GROUP INC (2.02M shares), D. E. Shaw & Co., Inc. (1.98M shares), STATE STREET CORP (1.9M shares), Boxer Capital, LLC (1.5M shares), GREAT POINT PARTNERS LLC (1.47M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.33M shares), RTW INVESTMENTS, LP (1.31M shares), J. Goldman & Co LP (1.26M shares), and Camber Capital Management LLC (1.25M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.